3 surprisingly cheap stocks: AstraZeneca plc, Darty plc and WS Atkins plc

These three stocks offer significant upward rerating potential: AstraZeneca plc (LON: AZN), Darty plc (LON: DRTY) and WS Atkins plc (LON: ATK).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Multi-channel electrical retailer Darty (LSE: DRTY) released a rather mixed update today, with it recording lower profit but higher sales ahead of its acquisition by Groupe Fnac. Darty’s top line rose by 3.9% on a like-for-like (LFL) basis as online sales made a positive contribution. However, the company’s bottom line fell by 13.7% as a result of writedowns made after business disruption in the Netherlands following the implementation of a new IT system.

As mentioned, Darty is being acquired by Group Fnac and it appears to be buying the business at a cut-price. Certainly, the outlook for electrical retailers is somewhat uncertain and the European economy in particular is enduring a prolonged period of slow growth. However, with Darty expected to increase its bottom line by 26% in the current year and by a further 42% next year, it seems to be firing on all cylinders. In fact, such a strong rate of growth puts Darty on a price-to-earnings growth (PEG) ratio of just 0.5, which makes it a rather cheap business at the present time.

Discounted valuation

Also trading on a discounted valuation are shares in WS Atkins (LSE: ATK). The engineering and project management company today announced its full-year results, with its top line rising by 6% and underlying earnings being up 10.5% on a per share basis. This represents a significant improvement in the performance of WS Atkins’ UK and European segments, with two recent major transportation project wins in North America set to provide a boost to the company’s workload in the current financial year.

While Energy continues to be a tough space in which to operate for WS Atkins, its overall performance as a business remains sound. Looking ahead, it’s expected to grow its earnings by 5% in the current year and by 4% next year. While these rates of growth may not be particularly stunning, WS Atkins offers excellent value for money and the fact that its performance is improving could be enough to boost investor sentiment in the stock. And due to it having a price-to-earnings (P/E) ratio of 10.8, its shares could benefit from a substantial upward rerating over the coming years.

Bid potential

Meanwhile, shares in AstraZeneca (LSE: AZN) also continue to offer good value for money. They trade on a P/E ratio of 14 which, for a pharmaceutical major with a strong pipeline of new treatments, seems to be rather low.

Certainly, AstraZeneca continues to experience problems with its near-term financial outlook, with the company expected to report a fall in earnings in each of the next two financial years. However, this appears to be more than adequately priced-in and due to AstraZeneca having upbeat long-term growth prospects, its shares could begin to rise even if a bid approach isn’t received.

Clearly, AstraZeneca remains a company with bid potential. Its strong financial standing, excellent cash flow and rapidly evolving pipeline show that it remains a top quality business. Allied to this is a yield of 5.1%, which means that AstraZeneca’s total returns could be superb in the long run.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »